Repurposing of drugs: An attractive pharmacological strategy for cancer therapeutics

A Kirtonia, K Gala, SG Fernandes, G Pandya… - Seminars in cancer …, 2021 - Elsevier
Human malignancies are one of the major health-related issues though out the world and
anticipated to rise in the future. The development of novel drugs/agents requires a huge …

Statin drugs to reduce breast cancer recurrence and mortality

CH Beckwitt, A Brufsky, ZN Oltvai, A Wells - Breast Cancer Research, 2018 - Springer
Epidemiologic studies have, variably, shown the concomitant use of statin drugs to be
beneficial to cancer outcomes. Statin drugs have been FDA approved for three decades for …

Direct activation of Bax protein for cancer therapy

Z Liu, Y Ding, N Ye, C Wild, H Chen… - Medicinal research …, 2016 - Wiley Online Library
Bax, a central cell death regulator, is an indispensable gateway to mitochondrial dysfunction
and a major proapoptotic member of the B‐cell lymphoma 2 (Bcl‐2) family proteins that …

Lipophilic statins and risk for hepatocellular carcinoma and death in patients with chronic viral hepatitis: results from a nationwide Swedish population

TG Simon, AS Duberg, S Aleman… - Annals of internal …, 2019 - acpjournals.org
Background: Whether statin type influences hepatocellular carcinoma (HCC) incidence or
mortality in chronic hepatitis B or C virus infection is unknown. Objective: To assess the …

Examining bias in studies of statin treatment and survival in patients with cancer

L Emilsson, X García-Albéniz, RW Logan… - JAMA …, 2018 - jamanetwork.com
Importance Patients with cancer who use statins appear to have a substantially better
survival than nonusers in observational studies. However, this inverse association between …

Nonalcoholic fatty liver disease, diabetes, obesity, and hepatocellular carcinoma

M Noureddin, ME Rinella - Clinics in liver disease, 2015 - liver.theclinics.com
Nonalcoholic fatty liver disease (NAFLD) is now the most common liver disease in the
United States, with more than 80 million Americans affected. It represents a spectrum of …

[HTML][HTML] Cytoprotective remedies for ameliorating nephrotoxicity induced by renal oxidative stress

R Ranasinghe, M Mathai, A Zulli - Life Sciences, 2023 - Elsevier
Aims Nephrotoxicity is the hallmark of anti-neoplastic drug metabolism that causes oxidative
stress. External chemical agents and prescription drugs release copious amounts of free …

Targeting the mevalonate cascade as a new therapeutic approach in heart disease, cancer and pulmonary disease

B Yeganeh, E Wiechec, SR Ande, P Sharma… - Pharmacology & …, 2014 - Elsevier
The cholesterol biosynthesis pathway, also known as the mevalonate (MVA) pathway, is an
essential cellular pathway that is involved in diverse cell functions. The enzyme 3-hydroxy-3 …

The effect of statins on cancer cells

L Matusewicz, J Meissner, M Toporkiewicz, AF Sikorski - Tumor Biology, 2015 - Springer
Abstract Statins [3-hydroxy-3-methylglutaryl-coenzyme A reductase (HMG-CoA reductase,
abbreviated HMGCR) inhibitors], are well-known cholesterol-depleting agents. Since the …

[HTML][HTML] Tumor macroenvironment and metabolism

W Al-Zhoughbi, J Huang, GS Paramasivan, H Till… - Seminars in …, 2014 - Elsevier
In this review we introduce the concept of the tumor macroenvironment and explore it in the
context of metabolism. Tumor cells interact with the tumor microenvironment including …